We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
From the FDA.
- Abstract
The article offers news briefs related to medical care in the U.S. in 2008. The U.S. Food and Drug Administration (FDA) has approved the bupropion hydrobromide or Aplenzin of Biovail Corp. for treating major depressive disorder in adults. Dr. Murray Lumpkin, FDA Deputy Commissioner for International and Special Programs, offers his views on medical and regulatory issues affecting medicines for young patients in the column of "Andy's Take" journal on August 1.
- Subjects
UNITED States; UNITED States. Food &; Drug Administration; DRUG approval; BIOVAIL Corp.; DEPRESSED persons; LUMPKIN, Murray; MEDICAL care
- Publication
Brown University Child & Adolescent Psychopharmacology Update, 2008, Vol 10, Issue 10, p8
- ISSN
1527-8395
- Publication type
Article